David Skurnik

7.5k citations

56 papers · 4.8k indexed · 3 hit papers · h-index 31

Impact in

Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Endocrinology top 0.2%
- Escherichia coli research studies

Papers in

Molecular Medicine 23
- Antibiotic Resistance in Bacteria 23
Endocrinology 17
- Escherichia coli research studies 12
- Vibrio bacteria research studies 6

Co-authors: Érick Denamur Bertrand Picard Olivier Tenaillon Gerald B. Pier Hugues Aschard Damien Roux Harry Sokol Philippe Seksik
Journals: Clinical Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)PLoS Pathogens (3 papers)Environmental Microbiology (3 papers)Infection and Immunity (2 papers)
Partner nations: France United States French Guiana

In The Last Decade

David Skurnik

55 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections—a Time Series Analysis 2020 · 223 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Clinical Infectious Diseases
2016 Gut
2010 Nature Reviews Microbiology

Peers

Countries citing papers authored by David Skurnik

Since Specialization

Citations

This map shows the geographic impact of David Skurnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Skurnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Skurnik more than expected).

Fields of papers citing papers by David Skurnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Skurnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Skurnik. The network helps show where David Skurnik may publish in the future.

Co-authors

The 25 scholars most cited alongside David Skurnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Skurnik Line = papers co-authored together David Skurnik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae PLoS Pathogens ·Hedi Mammeri, Youssouf Sérémé, Eya Toumi, Hélène Faury, David Skurnik	2025	1
2	A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens npj Vaccines ·Eliza Kramarska, Eya Toumi, Flavia Squeglia, Diana Laverde, Valeria Napolitano, Eric Frapy, Ida Autiero, Océane Sadonès, Johannes Hüebner, David Skurnik, Felipe Romero‐Saavedra, Rita Berisio	2024	5
3	Molecular insights into the evolutionary trajectory of a Klebsiella aerogenes clinical isolate with a complex trade-off between resistance and virulence Antimicrobial Agents and Chemotherapy ·Youssouf Sérémé, Hélène Faury, Victor Gravrand, Elisabeth Ageron, Claire Poyart, David Skurnik, Hedi Mammeri	2024	0
4	Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections PLoS Pathogens ·Kenneth D. Johnson, James C. Delaney, Thomas Guillard, Fany Reffuveille, Jennifer Varin, Kai Li, Andrew M. Wollacott, Eric Frapy, Surin K. Mong, Hamid Tissire, Karthik Viswanathan, Fayçal Touti, Gregory J. Babcock, Zachary Shriver, Bradley L. Pentelute, Obadiah J. Plante, David Skurnik	2023	17
5	Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis Annals of the Rheumatic Diseases ·David Moulin, Marie Millard, Mahdia Taïeb, Chloé Michaudel, Anne Aucouturier, Antoine Lefèvre, Luis G. Bermúdez‐Humarán, Philippe Langella, Youssouf Sérémé, Kristell Wanherdrick, Preeti Gautam, Xavier Mariette, Philippe Dieudé, Jacques‐Eric Gottenberg, Jean‐Yves Jouzeau, David Skurnik, Patrick Emond, Denis Mulleman, Jérémie Sellam, Harry Sokol	2023	33
6	How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? Stem Cell Reviews and Reports ·Stéphanie Pons, Fabrice Uhel, Eric Frapy, Youssouf Sérémé, Lara Zafrani, Hugues Aschard, David Skurnik	2022	4
7	Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study Antiviral Research ·Susan Sloan, Kristy J. Szretter, Bharathi Sundaresh, Kristin Narayan, Patrick F. Smith, David Skurnik, Sylvain Bédard, José Trevejo, David Oldach, Zachary Shriver	2020	20
8	Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy BioEssays ·Thomas Guillard, Stéphanie Pons, Damien Roux, Gerald B. Pier, David Skurnik	2016	37
9	Fungal microbiota dysbiosis in IBD Gut ·Harry Sokol, Valentin Leducq, Hugues Aschard, Hang‐Phuong Pham, Sarah Jégou, Cécilia Landman, David Cohen, Giuseppina Liguori, Anne Bourrier, Isabelle Nion–Larmurier, Jacques Cosnes, Philippe Seksik, Philippe Langella, David Skurnik, Mathias L. Richard, Laurent Beaugerie Hit paper breakdown →	2016	939
10	Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing Proceedings of the National Academy of Sciences ·David Skurnik, Damien Roux, Vincent Cattoir, Olga Danilchanka, Xi Lü, Deborah R. Yoder-Himes, Kook Han, Thomas Guillard, Deming Jiang, Charlotte Gaultier, François Guérin, Hugues Aschard, Roland Leclercq, John J. Mekalanos, Stephen Lory, Gerald B. Pier	2013	100
11	A Comprehensive Analysis of In Vitro and In Vivo Genetic Fitness of Pseudomonas aeruginosa Using High-Throughput Sequencing of Transposon Libraries PLoS Pathogens ·David Skurnik, Damien Roux, Hugues Aschard, Vincent Cattoir, Deborah R. Yoder-Himes, Stephen Lory, Gerald B. Pier	2013	127
12	Natural Antibodies in Normal Human Serum Inhibit Staphylococcus aureus Capsular Polysaccharide Vaccine Efficacy Clinical Infectious Diseases ·David Skurnik, Andrea Kropec, Damien Roux, Christian Theilacker, Johannes Hüebner, Gerald B. Pier	2012	41
13	Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes Journal of Antimicrobial Chemotherapy ·Damien Roux, Gerald B. Pier, David Skurnik	2012	26
14	Emergence and Dissemination of Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliin the Community: Lessons from the Study of a Remote and Controlled Population The Journal of Infectious Diseases ·Paul‐Louis Woerther, Cécile Angebault, Mathilde Lescat, Étienne Ruppé, David Skurnik, Assiya El Mniai, Olivier Clermont, Hervé Jacquier, Anaelle Da Costa, Magaly Renard, Régis Marc Bettinger, Loïc Epelboin, Claire Dupont, Didier Guillemot, François Rousset, Guillaume Arlet, Érick Denamur, Félix Djossou, Antoine Andremont	2010	51
15	The population genetics of commensal Escherichia coli Nature Reviews Microbiology ·Olivier Tenaillon, David Skurnik, Bertrand Picard, Érick Denamur Hit paper breakdown →	2010	1046
16	Rapid Adaptation of Antibiotic Therapy for Community-Acquired Peritonitis Using Direct Cultures on Antibiotic Agar Plates: Pilot Study Surgical Infections ·Sigismond Lasocki, David Skurnik, Claudette Muller‐Serieys, Régis Bronchard, Candice Marcel, Jean–Pierre Marmuse, Philippe Montravers, Antoine Andremont	2009	1
17	Integrons and Antibiotic Resistance in Phylogenetic Group B2 Escherichia coli Microbial Drug Resistance ·David Skurnik, Sonia Lacheeb, Claire Bernède, Arnaud Le Menach, Sandrine Elbaz, J. Mohler, Érick Denamur, Antoine Andremont, Raymond Ruimy	2009	12
18	Organic and conventional fruits and vegetables contain equivalent counts of Gram‐negative bacteria expressing resistance to antibacterial agents Environmental Microbiology ·Raymond Ruimy, Anne Brisabois, Claire Bernède, David Skurnik, Saïda Barnat, Guillaume Arlet, Sonia Momcilovic, Sandrine Elbaz, Frédérique Moury, Marie‐Anne Vibet, Patrice Courvalin, Didier Guillemot, Antoine Andremont	2009	96
19	CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation Nature Medicine ·Fabiano Pinheiro da Silva, Meryem Aloulou, David Skurnik, Marc Benhamou, Antoine Andremont, Irineu Tadeu Velasco, Murilo Chiamolera, J. Sjef Verbeek, Pierre Launay, Renato C. Monteiro	2007	118
20	Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli Journal of Antimicrobial Chemotherapy ·David Skurnik	2006	186

About David Skurnik

David Skurnik is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Infectious Diseases and Microbiology, having authored 56 papers that have together received 4.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (23 papers), Escherichia coli research studies (12 papers), Bacterial biofilms and quorum sensing (7 papers), Evolution and Genetic Dynamics (6 papers), Pneumonia and Respiratory Infections (6 papers), Vibrio bacteria research studies (6 papers), Bacteriophages and microbial interactions (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (5 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Endocrinology (1.2k citations), Applied Microbiology and Biotechnology (173 citations), Infectious Diseases (949 citations) and Pollution (520 citations). David Skurnik has collaborated with scholars based in France, United States and French Guiana. Frequent co-authors include Érick Denamur, Bertrand Picard, Olivier Tenaillon, Gerald B. Pier, Hugues Aschard, Damien Roux, Harry Sokol, Philippe Seksik, Jacques Cosnes and Laurent Beaugerie. Their work appears in journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, PLoS Pathogens, Environmental Microbiology and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact